Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country

Vaccine

Volumn 35, Issue 2, 2017, Pages 321-328

  Akhtar, Marjahan ^a   Qadri, Firdausi ^a   Bhuiyan, Taufiqur R ^a   Akter, Sarmin ^a   Rafique, Tanzeem A ^a   Khan, Arifuzzaman ^a   Islam, Laila N ^b   Saha, Amit ^a   Svennerholm, Ann Mari ^c   Lundgren, Anna ^c  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF DHAKA   (Bangladesh)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antibodies in lymphocyte supernatant; Antibody secreting cell; Children; Cholera; IgA; Oral vaccine

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; SECRETORY IMMUNOGLOBULIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ARTICLE; BANGLADESH; CHILD; CHOLERA; DRUG SAFETY; DRUG TOLERABILITY; FECES; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LYMPHOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION; ADOLESCENT; BLOOD; CHEMISTRY; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; TIME FACTOR; VIBRIO CHOLERAE; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODY-PRODUCING CELLS; BANGLADESH; CHILD, PRESCHOOL; CHOLERA VACCINES; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; TIME FACTORS; VIBRIO CHOLERAE; YOUNG ADULT;

EID: 85007003699     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.11.055     Document Type: Article

References (34)

1. [1] Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J.E., et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385:9966 (2015), 430–440.
2. [2] Czerkinsky, C., Holmgren, J., Vaccines against enteric infections for the developing world. Philos Trans R Soc Lond B Biol Sci, 370(1671), 2015.
3. [3] Ahren, C., Jertborn, M., Svennerholm, A.M., Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood. Infect Immun 66:7 (1998), 3311–3316.
4. [4] Wenneras, C., Qadri, F., Bardhan, P.K., Sack, R.B., Svennerholm, A.M., Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect Immun 67:12 (1999), 6234–6241.
5. [5] Shamsuzzaman, S., Ahmed, T., Mannoor, K., Begum, Y.A., Bardhan, P.K., Sack, R.B., et al. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses. Vaccine 27:9 (2009), 1386–1392.
6. [6] Kantele, A., Peripheral blood antibody-secreting cells in the evaluation of the immune response to an oral vaccine. J Biotechnol 44:1–3 (1996), 217–224.
7. [7] Saletti, G., Cuburu, N., Yang, J.S., Dey, A., Czerkinsky, C., Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood. Nat Prot 8:6 (2013), 1073–1087.
8. [8] Carpenter, C.M., Hall, E.R., Randall, R., McKenzie, R., Cassels, F., Diaz, N., et al. Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers. Vaccine 24:18 (2006), 3709–3718.
9. [9] Lundgren, A., Kaim, J., Jertborn, M., Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods. Vaccine 27:33 (2009), 4529–4536.
10. [10] Sack, D., Qadri, F., Svennerholm, A.-M., Determinants of responses to oral vaccines in developing countries. Ann Nestlé (Engl) 66 (2008), 71–79.
11. [11] Leach, S., Lundgren, A., Svennerholm, A.M., Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memory. Vaccine 31:30 (2013), 3035–3038.
12. [12] Lundgren, A., Bourgeois, L., Carlin, N., Clements, J., Gustafsson, B., Hartford, M., et al. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study. Vaccine 32:52 (2014), 7077–7084.
13. [13] Lundgren, A., Jertborn, M., Svennerholm, A.M., Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine. Vaccine, 2016 Accepted for publication.
14. [14] Wenneras, C., Svennerholm, A.M., Ahren, C., Czerkinsky, C., Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect Immun 60:7 (1992), 2605–2611.
15. [15] Savarino, S.J., Brown, F.M., Hall, E., Bassily, S., Youssef, F., Wierzba, T., et al. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults. J Infect Dis 177:3 (1998), 796–799.
16. [16] Savarino, S.J., Hall, E.R., Bassily, S., Brown, F.M., Youssef, F., Wierzba, T.F., et al. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group. J Infect Dis 179:1 (1999), 107–114.
17. [17] Qadri, F., Wenneras, C., Ahmed, F., Asaduzzaman, M., Saha, D., Albert, M.J., et al. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children. Vaccine 18:24 (2000), 2704–2712.
18. [18] Qadri, F., Ahmed, T., Ahmed, F., Bradley Sack, R., Sack, D.A., Svennerholm, A.M., Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18–36 months of age. Vaccine 21:19–20 (2003), 2394–2403.
19. [19] Harro, C., Sack, D., Bourgeois, A.L., Walker, R., DeNearing, B., Feller, A., et al. A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol 18:12 (2011), 2118–2127.
20. [20] Jertborn, M., Svennerholm, A.M., Holmgren, J., Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine. Vaccine 14:15 (1996), 1459–1465.
21. [21] Quiding, M., Nordstrom, I., Kilander, A., Andersson, G., Hanson, L.A., Holmgren, J., et al. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest 88:1 (1991), 143–148.
22. [22] Lundgren, A., Leach, S., Tobias, J., Carlin, N., Gustafsson, B., Jertborn, M., et al. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Vaccine 31:8 (2013), 1163–1170.
23. [23] Bhuiyan, T.R., Choudhury, F.K., Khanam, F., Saha, A., Sayeed, M.A., Salma, U., et al. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Vaccine 32:9 (2014), 1055–1060.
24. [24] Kilhamn, J., Jertborn, M., Svennerholm, A.M., Kinetics of local and systemic immune responses to an oral cholera vaccine given alone or together with acetylcysteine. Clin Diagn Lab Immunol 5:2 (1998), 247–250.
25. [25] Qadri, F., Ahmed, T., Ahmed, F., Bhuiyan, M.S., Mostofa, M.G., Cassels, F.J., et al. Mucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coli. Infect Immun 75:5 (2007), 2269–2274.
26. high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71:4 (2003), 1755–1762.
27. [27] Svennerholm, A.M., Lundgren, A., Recent progress toward an enterotoxigenic Escherichia coli vaccine. Exp Rev Vaccines 11:4 (2012), 495–507.
28. [28] Quiding-Jarbrink, M., Nordstrom, I., Granstrom, G., Kilander, A., Jertborn, M., Butcher, E.C., et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 99:6 (1997), 1281–1286.
29. [29] Kantele, A., Kantele, J.M., Savilahti, E., Westerholm, M., Arvilommi, H., Lazarovits, A., et al. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. J Immunol 158:2 (1997), 574–579.
30. [30] Glass, R.I., Svennerholm, A.M., Stoll, B.J., Khan, M.R., Hossain, K.M., Huq, M.I., et al. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med 308:23 (1983), 1389–1392.
31. [31] Jertborn, M., Svennerholm, A.M., Holmgren, J., Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol 24:2 (1986), 203–209.
32. [32] Nathavitharana, K.A., Catty, D., Raykundalia, C., McNeish, A.S., Presence of secretory IgA antibodies to an enteric bacterial pathogen in human milk and saliva. Arch Dis Child Fetal Neonatal Ed 72:2 (1995), F102–F106.
33. [33] Stoll, B.J., Svennerholm, A.M., Gothefors, L., Barua, D., Huda, S., Holmgren, J., Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area. J Infect Dis 153:3 (1986), 527–534.
34. [34] WHO global data bank on infant and young child feeding. < http://wwwwhoint/nutrition/databases/infantfeeding/en/>; 2010.